Health Insurer Strategies to Reduce Specialty Drug Spending—Copayment Adjustment and Alternative Funding Programs
JAMA Internal Medicine · 01.07.2023 · 183 (7) · 635
DOI: 10.1001/jamainternmed.2023.1829 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Internal Medicine, erschienen am 01.07.2023. Verfasst von Autumn D Zuckerman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, Tennessee. Hauptthemen laut MEDLINE: Insurance Carriers, Health Benefit Plans, Employee. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
This Viewpoint describes programs intended to help patients with commercial insurance that, instead, employers, health plans, and other payers use to reduce their spending on specialty drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, Tennessee.
- Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee.
Zitieren
APA
Zuckerman, A. D., Schneider, M. P., & Dusetzina, S. B. (2023). Health Insurer Strategies to Reduce Specialty Drug Spending—Copayment Adjustment and Alternative Funding Programs. JAMA Internal Medicine, 183(7), 635. https://doi.org/10.1001/jamainternmed.2023.1829
Vancouver
Zuckerman AD, Schneider MP, Dusetzina SB. Health Insurer Strategies to Reduce Specialty Drug Spending—Copayment Adjustment and Alternative Funding Programs. JAMA Internal Medicine. 2023;183(7):635. doi:10.1001/jamainternmed.2023.1829
BibTeX
@article{Zuckerman2023,
author = {Zuckerman, Autumn D and Schneider, Megan P and Dusetzina, Stacie B},
title = {Health Insurer Strategies to Reduce Specialty Drug Spending—Copayment Adjustment and Alternative Funding Programs},
journal = {JAMA Internal Medicine},
year = {2023},
volume = {183},
number = {7},
pages = {635},
doi = {10.1001/jamainternmed.2023.1829}
}
EUVIMED